Well Lead Med Co Ltd (603309) - Total Assets
Based on the latest financial reports, Well Lead Med Co Ltd (603309) holds total assets worth CN¥2.73 Billion CNY (≈ $398.78 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Well Lead Med Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Well Lead Med Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Well Lead Med Co Ltd (603309) total market value for the company's overall valuation and market capitalisation.
Well Lead Med Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Well Lead Med Co Ltd's total assets of CN¥2.73 Billion consist of 33.8% current assets and 66.2% non-current assets. Review Well Lead Med Co Ltd (603309) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 8.9% |
| Accounts Receivable | CN¥212.15 Million | 7.4% |
| Inventory | CN¥189.05 Million | 6.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥170.48 Million | 6.0% |
| Goodwill | CN¥145.58 Million | 5.1% |
Asset Composition Trend (2011–2025)
This chart illustrates how Well Lead Med Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Well Lead Med Co Ltd for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Well Lead Med Co Ltd's current assets represent 33.8% of total assets in 2025, a decrease from 53.0% in 2011.
- Cash Position: Cash and equivalents constituted 8.9% of total assets in 2025, down from 16.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 12.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 7.4% of total assets.
Well Lead Med Co Ltd Competitors by Total Assets
Key competitors of Well Lead Med Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Well Lead Med Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.74 | 1.78 | 1.64 |
| Quick Ratio | 1.33 | 1.38 | 1.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥362.90 Million | CN¥390.81 Million | CN¥192.96 Million |
Well Lead Med Co Ltd - Advanced Valuation Insights
This section examines the relationship between Well Lead Med Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | 0.7% |
| Total Assets | CN¥2.86 Billion |
| Market Capitalization | $455.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Well Lead Med Co Ltd's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Well Lead Med Co Ltd's assets grew by 0.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Well Lead Med Co Ltd (2011–2025)
The table below shows the annual total assets of Well Lead Med Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.86 Billion ≈ $418.57 Million |
+0.70% |
| 2024-12-31 | CN¥2.84 Billion ≈ $415.68 Million |
+9.04% |
| 2023-12-31 | CN¥2.61 Billion ≈ $381.23 Million |
+9.30% |
| 2022-12-31 | CN¥2.38 Billion ≈ $348.80 Million |
+11.78% |
| 2021-12-31 | CN¥2.13 Billion ≈ $312.03 Million |
+43.23% |
| 2020-12-31 | CN¥1.49 Billion ≈ $217.85 Million |
+2.27% |
| 2019-12-31 | CN¥1.46 Billion ≈ $213.02 Million |
+2.92% |
| 2018-12-31 | CN¥1.41 Billion ≈ $206.98 Million |
+39.95% |
| 2017-12-31 | CN¥1.01 Billion ≈ $147.90 Million |
+3.91% |
| 2016-12-31 | CN¥972.68 Million ≈ $142.33 Million |
+10.40% |
| 2015-12-31 | CN¥881.08 Million ≈ $128.93 Million |
+67.57% |
| 2014-12-31 | CN¥525.80 Million ≈ $76.94 Million |
+11.04% |
| 2013-12-31 | CN¥473.51 Million ≈ $69.29 Million |
+15.73% |
| 2012-12-31 | CN¥409.14 Million ≈ $59.87 Million |
+12.00% |
| 2011-12-31 | CN¥365.30 Million ≈ $53.45 Million |
-- |
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more